Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Breast Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Platinum vs non‐platinum therapy

Time to progression · women with metastatic triple‐negative breast cancer (mTNBC)

It is very uncertain whether platinum changes progression‐free survival/time to progression (PFS/TTP) compared with non‐platinum regimens (very low certainty).

1 finding from 1 review

Platinum‐containing regimens for triple‐negative metastatic breast cancer 2020 · Cochrane Headline outcomes only
HR 0.77 [0.68, 0.88]
8 studies · 1077 participants
Very low